$1.92 $0.37 (23.9%)

04:00 PM EST on 12/06/19

Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB)

CAPS Rating: 1 out of 5

Current Price $1.92 Mkt Cap $312.5M
Open $1.60 P/E Ratio 0.00
Prev. Close $1.55 Div. (Yield) $0.00 (0.0%)
Daily Range $1.59 - $1.95 Volume 848,952
52-Wk Range $0.58 - $1.95 Avg. Daily Vol. 1,807,151

Caps

How do you think NYSEMKT:MTNB will perform against the market?

Add Stock to CAPS Watchlist

All Players

6 Outperform
22 Underperform
 

All-Star Players

1 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:MTNB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

TSIF (99.97)
Submitted January 30, 2017

ACEOTC$118M Market cap which is 47X book (0.05)."a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections. "14 Nov 2016 10-K"We are a clinical stage company… More

NYSEMKT:MTNB VS S&P 500 (SPY)

NYSEMKT:MTNB Summary

Fools bullish on NYSEMKT:MTNB are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MTNB.

Recs

0
Member Avatar Paco57 (< 20) Submitted: 12/6/2019 12:22:24 PM : Outperform Start Price: $1.84 NYSE MKT:MTNB Score: +4.46

I bought in!

Recs

0
Member Avatar kdakota630 (30.35) Submitted: 3/1/2019 1:21:34 PM : Underperform Start Price: $1.44 NYSE MKT:MTNB Score: -20.76

Whoa, Nellie, not so fast fella. Look out below. No way! Back to reality. Not a good pick. Not now. Wrong logic at this point. Gravity calls. Watch out on this one. Not at all optimistic. Pessimism reigns. Downward trend continues. Likely to continue to underperform. More downside imminent. Danger danger, at least for the next month. So obvious. Right direction now. Diminishing in value currently. Not impressive right now. Nonsense stock. Likely to fall in value.

Recs

0
Member Avatar Reydad92 (< 20) Submitted: 10/21/2018 2:40:49 PM : Outperform Start Price: $0.90 NYSE MKT:MTNB Score: +99.67

New groundbreaking technology, a clear disruptor.
Potentially applicable in all pharmacological therapies.

Leaderboard

Find the members with the highest scoring picks in MTNB.

Score Leader

SmartAce

SmartAce (99.97) Score: +119.00

The Score Leader is the player with the highest score across all their picks in MTNB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WasGibt < 20 11/7/2018 Outperform 5Y $0.89 +115.73% +13.43% +102.30 0 Comment
Reydad92 < 20 10/22/2018 Outperform 5Y $0.90 +113.33% +13.66% +99.67 1 Comment
quinpeung 79.01 1/14/2019 Outperform 5Y $0.97 +98.82% +22.58% +76.24 0 Comment
tsperbeck 99.68 4/28/2017 Underperform 1Y $2.75 -30.18% +32.26% +62.45 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TSIF 99.97 1/30/2017 1/24/2019 Underperform 1Y $2.15 -10.70% +38.29% +48.98 1 Comment
WSMOOT19 72.21 6/27/2017 10/9/2019 Underperform 3Y $2.00 -4.00% +29.55% +33.55 0 Comment
RossEnd 92.79 8/14/2017 Outperform 5Y $1.42 +35.21% +27.68% +7.53 0 Comment
Paco57 < 20 12/6/2019 Outperform 5Y $1.84 +4.35% -0.11% +4.46 1 Comment
cashsage 99.46 12/6/2019 Underperform 5Y $1.69 +13.61% -0.09% -13.70 0 Comment
constructive 99.96 12/12/2017 Underperform 5Y $1.42 +35.21% +18.11% -17.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MTNB.